149 related articles for article (PubMed ID: 15322172)
1. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.
Makita S; Kanai T; Oshima S; Uraushihara K; Totsuka T; Sawada T; Nakamura T; Koganei K; Fukushima T; Watanabe M
J Immunol; 2004 Sep; 173(5):3119-30. PubMed ID: 15322172
[TBL] [Abstract][Full Text] [Related]
2. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3.
Hong J; Li N; Zhang X; Zheng B; Zhang JZ
Proc Natl Acad Sci U S A; 2005 May; 102(18):6449-54. PubMed ID: 15851684
[TBL] [Abstract][Full Text] [Related]
3. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo.
Read S; Greenwald R; Izcue A; Robinson N; Mandelbrot D; Francisco L; Sharpe AH; Powrie F
J Immunol; 2006 Oct; 177(7):4376-83. PubMed ID: 16982872
[TBL] [Abstract][Full Text] [Related]
4. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.
Walker MR; Kasprowicz DJ; Gersuk VH; Benard A; Van Landeghen M; Buckner JH; Ziegler SF
J Clin Invest; 2003 Nov; 112(9):1437-43. PubMed ID: 14597769
[TBL] [Abstract][Full Text] [Related]
5. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.
Galustian C; Meyer B; Labarthe MC; Dredge K; Klaschka D; Henry J; Todryk S; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB; Dalgleish AG
Cancer Immunol Immunother; 2009 Jul; 58(7):1033-45. PubMed ID: 19009291
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation.
Read S; Malmström V; Powrie F
J Exp Med; 2000 Jul; 192(2):295-302. PubMed ID: 10899916
[TBL] [Abstract][Full Text] [Related]
7. Regulatory potential and control of Foxp3 expression in newborn CD4+ T cells.
Dujardin HC; Burlen-Defranoux O; Boucontet L; Vieira P; Cumano A; Bandeira A
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14473-8. PubMed ID: 15452347
[TBL] [Abstract][Full Text] [Related]
8. Compartment-driven imprinting of intestinal CD4 T cells in inflammatory bowel disease and homeostasis.
Lutter L; Ter Linde JJM; Brand EC; Hoytema van Konijnenburg DP; Roosenboom B; Horjus Talabur-Horje C; Oldenburg B; van Wijk F
Clin Exp Immunol; 2023 Dec; 214(3):235-248. PubMed ID: 37565620
[TBL] [Abstract][Full Text] [Related]
9. Reduced immune-regulatory molecule expression on human colonic memory CD4 T cells in older adults.
Dillon SM; Thompson TA; Christians AJ; McCarter MD; Wilson CC
Immun Ageing; 2021 Feb; 18(1):6. PubMed ID: 33581731
[TBL] [Abstract][Full Text] [Related]
10. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.
Walker MR; Carson BD; Nepom GT; Ziegler SF; Buckner JH
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4103-8. PubMed ID: 15753318
[TBL] [Abstract][Full Text] [Related]
11. Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15R alpha complex and CD4+ CD25+ T cells are the main targets.
Forest V; Pierre F; Bassonga E; Meflah K; Menanteau J
Cancer Immunol Immunother; 2005 Jan; 54(1):78-86. PubMed ID: 15693142
[TBL] [Abstract][Full Text] [Related]
12. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis.
Prakken BJ; Samodal R; Le TD; Giannoni F; Yung GP; Scavulli J; Amox D; Roord S; de Kleer I; Bonnin D; Lanza P; Berry C; Massa M; Billetta R; Albani S
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4228-33. PubMed ID: 15024101
[TBL] [Abstract][Full Text] [Related]
13. CD4
Arciniega-Martínez IM; Reséndiz Albor AA; Cárdenas Jaramillo LM; Gutiérrez-Meza JM; Falfán-Valencia R; Arroyo BM; Yépez-Ortega M; Pacheco-Yépez J; Abarca-Rojano E
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34958108
[TBL] [Abstract][Full Text] [Related]
14. Quantifying HIV-1-Mediated Gut CD4
Dillon SM; Guo K; Castleman MJ; Santiago ML; Wilson CC
Bio Protoc; 2020 Jan; 10(2):e3486. PubMed ID: 33654719
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
17. Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity.
Santosh Nirmala S; Kayani K; Gliwiński M; Hu Y; Iwaszkiewicz-Grześ D; Piotrowska-Mieczkowska M; Sakowska J; Tomaszewicz M; Marín Morales JM; Lakshmi K; Marek-Trzonkowska NM; Trzonkowski P; Oo YH; Fuchs A
Front Immunol; 2023; 14():1321228. PubMed ID: 38283365
[TBL] [Abstract][Full Text] [Related]
18. Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases.
Liu X; Wang X; Zhang P; Fang Y; Liu Y; Ding Y; Zhang W
Front Immunol; 2023; 14():1266792. PubMed ID: 38022571
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Immune Imbalance is an Alarm in the Development of IBD.
Hu C; Liao S; Lv L; Li C; Mei Z
Mediators Inflamm; 2023; 2023():1073984. PubMed ID: 37554552
[TBL] [Abstract][Full Text] [Related]
20. Exploring Colitis through Dynamic T Cell Adoptive Transfer Models.
Yang W; Cong Y
Inflamm Bowel Dis; 2023 Oct; 29(10):1673-1680. PubMed ID: 37536274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
